Therapeutic Area Strategy Head (RLT)

Band

Level 8

 

Job Description Summary

The Therapeutic Area Strategy Head, Radioligand Therapy (RLT) will lead a therapeutic area focused team in the creation and ongoing update of a holistic and aligned enterprise portfolio strategy for a key Novartis growth pillar, RLT. The candidate will work closely with the Research-Development-Commercial continuum + (RDC+), comprising of key functions within Biomedical Research (BR), Development and Commercial organizations in US and International. The candidate will bring a passion for innovation, deep RLT industry experience, scientific acumen and strong judgement to guide internal choices and drive sustainable growth in the short, mid and long-term for the platform. This individual will have both a broad and deep understanding of the RLT Platform, including imaging and isotopes, to derive insightful and differentiating competitive advantages over our peers by bringing a third-party view around key strategic levers and external analyses, trends, and white space opportunities. Additionally, they will conduct targeted primary research in Radioligand and the broader oncology space.

Location: this role can be based in Cambridge, MA or East Hanover, NJ US or Basel, Switzerland. If applying in Europe, please refer to REQ-10051090.

LI-#hybrid

 

Job Description

Your responsibilities include, but not limited to:

Provides external perspective and identifies opportunities:

• Builds and maintains in-depth knowledge of the TA (early pipeline to commercial); including disease models; responsible for ongoing assessment of peer companies with emerging exposure in the TA.
• Educates, updates and provides external views to all internal stakeholders.  Provides insight within key portfolio governance processes (diligence and external landscape mapping with BD&L and M&A)
• Supports identification of growth accretive opportunities, indications, disease spaces and rejection of low value opportunities/projects
• Supports Group Investor Relations and the CEO Office with dissemination of key strategic insights
• Ongoing collection and synthesis of scientific and commercial insights for the TA

Owns TA portfolio strategy and prioritization:

• Leads the process of creating, maintaining and updating enterprise-wide TA portfolio strategy; including DA, molecule and isotope selection to drive mid- and long-term growth in collaboration with RDC and RDC+

Internal and External Commercial and Pipeline Modelling:

• Oversees assessments of programs fit to current portfolio strategy and facilitates central review for assets inside and outside current priorities (e.g., at Innovation Management Board (IMB))
• Provides consolidated commercial and development inputs to support business cases for internal and external assets, programs and isotopes
• Provides outside-in independent view of internal assumptions around core pipeline
• Leads the development of assessment of external opportunities (e.g., forecast assumptions, business cases)

Others:

• Coaches, attracts, develops, and retains top talents; partners with P&O leadership to develop people strategy (e.g. organization development, performance, career development).
• Plans, allocates, and manages TA strategy financial budget by anticipating expenditures, accurately forecasting resource needs/costs and properly accounting for expenses to meet requirements and achieve fiscal responsibility

What you’ll bring to the role:

• Advanced degree or equivalent experience in life science/healthcare required; MBA highly desirable
• Excellent oral and written English communication skills.
• ≥10 years of pharmaceutical/biotech experience from either banking, consulting or biopharma covering drug development and ideally commercialization with an ability to work in a matrix environment
• >3 years of experience with RLT technology
• Ability to comfortably engage with the C-suite and mid-career associates to influence and challenge with excellent interpersonal and leadership skills
• Strong financial and business acumen with strong understanding of biopharma landscape; companies, assets and early technologies
• Strong strategic vision, superior leadership, excellent communication, consensus building, and well-developed influencing and negotiation skills
• Excellent conflict resolution skills to facilitate agreement and buy-in at the senior-most levels
• Experience leading and managing a team with a variety of insights from science to commercial